Meghan Good

Meghan Good
Meghan Good

Research Manager

Meghan holds a Master and bachelor’s degree in Neuroscience. During her master’s studies at Imperial College London, she completed research projects at the Computational, Cognitive and Clinical Neuroimaging Laboratory in brain imaging, psychedelic research and consciousness where she was awarded a distinction.

She joined Small Pharma in 2020 and now works as a research manager across preclinical and clinical programmes. Meghan is primarily responsible for pharmacokinetic and statistical analysis activities and the preclinical aspects of Small Pharma’s drug development programme. Meghan also assists with the development of experimental design, regulatory documentation and patent filing.

Before joining Small Pharma Meghan worked in management consulting and in clinical research in the department for reproductive health and childbirth within NHS.

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

Get Small Pharma
Investor Updates

    Investor Deck

    Follow us: